跳至主要内容
临床试验/JPRN-UMIN000035862
JPRN-UMIN000035862招募中2 期

Safety and efficacy of tick-borne encephalitis vaccine - TBEV2018

Sapporo City General Hospital0 个研究点目标入组 300 人开始时间: 2019年2月12日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients suspected with acute illness such as fever 2. Patients currently under treatment for any acute illness or patients who have not recovered from acute illness for more than 1 week 3. Severe immunodeficiency 4. History of severe adverse reaction or allergy after tick-borne encephalitis vaccine 5. Hypersensitivity to formaldehyde, neomycin, gentamycin, protamine sulfate) 6. Severe hypersensitivity to egg and chick proteins (anaphylactic reaction after oral ingestion of egg protein) 7. Severe hypersensitivity to latex (anaphylactic reaction to latex) 8. Pregnancy or breastfeeding 9. Participants who deemed inappropriate by principal investigator 10. For first time vaccination: tick bite within 4 weeks

研究者

相似试验

Safety and efficacy of tick-borne encephalitis... | 临床试验